Cardiac Dimensions®, Inc. today announced that it achieved the implant target for the TITAN™ safety study during the fourth quarter of 2008.
Supplement Features 15 Peer Reviewed Papers Describing CyberKnife Radiosurgery for Brain and Spine Applications
B. Braun gets favourable support from Penang State Government for Future Expansion Plans.
Agreement stops all litigation in interventional cardiology and endovascular repair.
Biomedical engineers at The University of Texas Health Science Center at Houston are leading a multi-institution initiative to produce a bio-compatible compound designed to mend serious leg fractures.
Innovative Medical Device Extends Possibility of Minimally Invasive Endovascular Repair of Aortic Aneurysms to More Patients
Smith & Nephew on Thursday said it had won a SFr159m ($141m, £109m) cut in the purchase price of Plus Orthopedics, the business which caused it to issue a shock profit warning in May last year.
Flexible Stenting Solutions, Inc., a leading developer of next-generation flexible stents, announced today it has received CE Mark for its FlexStent™ Femoropopliteal Self Expanding Stent System.
Life sciences company Entegrion continues to strengthen its leadership team with the addition of Peter C. Johnson, MD, who will serve as Executive Vice President and Chief Business Officer, effective
Study reports excellent long-term durability of the St. Jude Medical Biocor Stented Tissue Valve for mitral and aortic valve replacement
CUREXO Technology Corporation, pioneer in medical robotics and world leader in image-directed robotic products for orthopaedic applications, announced the addition of Brent D. Mittelstadt to its senior management team as President and Chief Executive Officer.
ArthroCare Corp. announced today that it received a letter from the Nasdaq Listing Qualifications Panel, dated January 14, 2009, stating that the Panel has determined to suspend and delist trading of the Company’s common stock on The Nasdaq Stock Market.
Biomet, Inc. announced today financial results for its second fiscal quarter ended November 30, 2008.
Allium Group announced today that it has been awarded CE mark for its prostatic stent enabling commercialization of the system in the European Union and the countries that recognize the CE Mark.
St. Jude Medical, Inc. (NYSE: STJ ) celebrates the 50th anniversary of the world’s first implantable pacemaker.
Why do hip replacements fail?